AG101

N/A

Report date: 2023/06/16 17:55:15
NME

Base Information

Drug NameAG101
Drug Alias NameAG101AG-101
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAngiogenesis inhibitorsEpidermal growth factor inhibitorsLaminin receptors antagonists
TargetsEpidermal growth factorLaminin receptors
Therapy Area/IndicationsLung NeoplasmsBrain NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArrogene Inc
China Registration ClassN/A

Develop Information

Active CompaniesArrogene Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsBrain NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A